Amara Financial LLC. Purchases Shares of 5,450 Amedisys, Inc. (NASDAQ:AMED)

Amara Financial LLC. acquired a new position in Amedisys, Inc. (NASDAQ:AMEDFree Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,450 shares of the health services provider’s stock, valued at approximately $526,000. Amedisys accounts for approximately 0.5% of Amara Financial LLC.’s portfolio, making the stock its 26th biggest position.

Several other institutional investors also recently modified their holdings of AMED. SG Americas Securities LLC increased its stake in Amedisys by 41.6% in the second quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock valued at $3,517,000 after acquiring an additional 11,264 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after buying an additional 19,660 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Amedisys by 65.8% during the 1st quarter. California State Teachers Retirement System now owns 54,592 shares of the health services provider’s stock worth $5,031,000 after buying an additional 21,671 shares during the period. Cetera Advisors LLC bought a new position in shares of Amedisys during the 1st quarter worth approximately $1,556,000. Finally, Murchinson Ltd. boosted its stake in Amedisys by 69.2% in the 2nd quarter. Murchinson Ltd. now owns 123,979 shares of the health services provider’s stock valued at $11,381,000 after buying an additional 50,716 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Price Performance

Amedisys stock opened at $89.45 on Tuesday. The business’s fifty day moving average is $95.88 and its two-hundred day moving average is $95.83. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a market cap of $2.93 billion, a P/E ratio of 35.50, a P/E/G ratio of 1.87 and a beta of 0.78. Amedisys, Inc. has a 52 week low of $88.98 and a 52 week high of $98.95.

Amedisys (NASDAQ:AMEDGet Free Report) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. During the same period in the prior year, the firm earned $0.98 earnings per share. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. Equities research analysts forecast that Amedisys, Inc. will post 4.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AMED has been the subject of several recent analyst reports. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price for the company. in a research report on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $100.67.

Check Out Our Latest Report on Amedisys

About Amedisys

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Stories

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.